Phase I Study of VLX-1005 in Healthy Subjects

Clinical trial NCT04783545 · COMPLETED

Trial details

NCT number: NCT04783545
Sponsor: Veralox Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety and Tolerability in Healthy Volunteers

Start date: 2021-03-24
Primary completion: 2022-01-11
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.